{"entity":{"id":"nct05910827","kind":"trial","name":"A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers","aka":[],"tldr":"A phase 1/2 trial of HMBD-001, Docetaxel, Cetuximab in non-small-cell lung cancer and small-cell lung cancer, run by Hummingbird Bioscience, now recruiting.","summary":"A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers is a phase 1/2 interventional study registered as NCT05910827 by Hummingbird Bioscience, with 398 participants planned, started 2024-02-05 and due to reach its primary completion in 2027-12-01. Interventions recorded: HMBD-001, Docetaxel, Cetuximab. Conditions listed: Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT05910827","url":"https://clinicaltrials.gov/study/NCT05910827"}],"tags":["ctgov-ingest"],"related":[],"cancers":["nsclc","sclc","head-and-neck","cutaneous-scc"],"sections":[],"technologies":[],"targets":[],"drugs":["hmbd-001","docetaxel","cetuximab"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT05910827","phase":"1/2","setting":"A Phase Ib/II Study to Evaluate HMBD-001 in Combination With Cetuximab, With or Without Docetaxel in Participants With Advanced Squamous Cell Carcinomas","sponsor":"Hummingbird Bioscience","enrolled":398,"outcomes":[]},"route":"/trials/nct05910827/","neighbours":{"cancer":[{"id":"cutaneous-scc","kind":"cancer","name":"Cutaneous squamous cell carcinoma","route":"/cancers/cutaneous-scc/"},{"id":"head-and-neck","kind":"cancer","name":"Head and neck squamous cell carcinoma","route":"/cancers/head-and-neck/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"sclc","kind":"cancer","name":"Small-cell lung cancer","route":"/cancers/sclc/"}],"drug":[{"id":"cetuximab","kind":"drug","name":"Cetuximab","route":"/drugs/cetuximab/"},{"id":"docetaxel","kind":"drug","name":"Docetaxel","route":"/drugs/docetaxel/"},{"id":"hmbd-001","kind":"drug","name":"HMBD-001","route":"/drugs/hmbd-001/"}]}}